Monday, November 21, 2016

BRIEF-Onxeo announces another positive DSMB recommendation for Livatag

* Announces 9th positive DSMB recommendation to continue

Livatag relive phase III trial in HCC

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)